The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

Trump Administration Warns 500+ Hospitals on Price Transparency

The Trump administration has warned more than 500 hospitals that they are failing to give the public basic pricing information and could face fines, STAT News reports. The notices mark a sharp escalation in enforcement of federal price transparency rules that have technically been in force since 2021 but that many hospitals have ignored or only partially followed.

Under those rules, hospitals are required to post the prices they negotiate with insurers, along with cash and discounted rates, in formats patients can actually use. Compliance has been uneven across the industry, with many facilities posting incomplete files or burying data in hard-to-find pages. The warnings put hundreds of hospitals on notice that regulators are now checking, and that penalties are on the table for those that do not fix their disclosures.

For hospital executives, the message is that transparency requirements are no longer a low-priority box to check. For patients, employers, and insurers, more complete pricing data could sharpen comparison shopping and negotiations.

Sources

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.